Abiopharma

Disc Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference

FibroBiologics CEO Issues Letter to Shareholders

Palisade Bio Announces Strategic Equity Investment from the Crohns & Colitis Foundations IBD Ventures Program to Advance PALI-2108

Palisade Bio Announces Strategic Equity Investment from the Crohn’s & Colitis Foundation’s IBD Ventures Program to Advance PALI-2108

SeaStar Medical Announces 2026 Milestones

ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus

Natera - Exelixis and Natera to Collaborate on STELLAR-316, a Phase 3 Pivotal Trial of Zanzalintinib for Patients with Colorectal Cancer

Rigel to Present at the 44th Annual J.P. Morgan Healthcare Conference

Harmony Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

Inspire Medical Systems, Inc. - Inspire Medical Systems, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026